Talking Medicines
Glasgow
About Talking Medicines
Talking Medicines provides Pharma and Med Comms agencies with AI-powered intelligence to measure, predict, and prove the impact of scientific messaging on HCPs. Using proprietary platforms, DrugVoice and the Message Resonance Score™, the company addresses a $23Bn marketing blind spot, connecting messaging to real-world prescribing behaviour. Its domain-specific data science enables clients to optimise campaigns, de-risk marketing investment, and demonstrate measurable ROI, positioning Talking Medicines as a strategic, high-value solution in the life sciences marketing ecosystem.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.3M
- Last round: Series Unknown (Feb 2022)
- Website: talkingmedicines.com
- Phone: 00 44 141 222 2212
Industries & Categories
Artificial Intelligence (AI), Business Intelligence, Data Visualization, Health Care, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/talking-medicines-62685 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.